Literature DB >> 24305532

Osteoporosis in postmenopausal women: considerations in prevention and treatment: (women's health series).

Suzanne Sanders1, Stephen A Geraci.   

Abstract

Osteoporosis, the most common human bone disease, affects 8 million American women and has significant morbidity and mortality. Screening is important in older women and younger postmenopausal women with additional risk factors for osteoporosis/fracture. Preventive measures include avoiding smoking, excessive alcohol/caffeine intake, and falls in addition to maintaining adequate calcium/vitamin D intake and exercise. Estrogen/hormone therapy may be considered in some patients. Various medications have proven efficacy in treating postmenopausal osteoporosis; however, potential adverse effects such as hypocalcemia, worsening of renal impairment, and osteonecrosis of the jaw must be considered. The optimal duration of therapy requires further investigation.

Entities:  

Mesh:

Year:  2013        PMID: 24305532     DOI: 10.1097/SMJ.0b013e3182a0df8b

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  12 in total

1.  Suppression effect of N-acetylcysteine on bone loss in ovariectomized mice.

Authors:  Xun Zhou; Zhengbo Wang; Yihong Ni; Yue Yu; Guantong Wang; Lulu Chen
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

2.  Osteoporosis Self-Assessment Tool for Asians Can Predict Neurologic Prognosis in Patients with Isolated Moderate Traumatic Brain Injury.

Authors:  Chia-Hung Chao; Yu-Feng Su; Hon-Man Chan; Shiuh-Lin Huang; Chih-Lung Lin; Aij-Lie Kwan; Yun-Ting Lou; Chao-Wen Chen
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

3.  Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis.

Authors:  Jia Meng; Dapeng Zhang; Nanan Pan; Ning Sun; Qiujun Wang; Jingxue Fan; Ping Zhou; Wenliang Zhu; Lihong Jiang
Journal:  PeerJ       Date:  2015-05-21       Impact factor: 2.984

4.  Treatment effect of Bushen Huayu extract on postmenopausal osteoporosis in vivo.

Authors:  Lu Ouyang; Qiufang Zhang; Xuzhi Ruan; Yibin Feng; Xuanbin Wang
Journal:  Exp Ther Med       Date:  2014-04-02       Impact factor: 2.447

Review 5.  Dietary Polyphenols, Berries, and Age-Related Bone Loss: A Review Based on Human, Animal, and Cell Studies.

Authors:  Patrice A Hubert; Sang Gil Lee; Sun-Kyeong Lee; Ock K Chun
Journal:  Antioxidants (Basel)       Date:  2014-03-11

Review 6.  The association between Vitamin D and health outcomes in women: A review on the related evidence.

Authors:  Nahid Ramezani Jolfaie; Mohammad Hossein Rouhani; Shokouh Onvani; Leila Azadbakht
Journal:  J Res Med Sci       Date:  2016-09-01       Impact factor: 1.852

7.  Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice.

Authors:  Xue-Ju Li; Zhe Zhu; Si-Lin Han; Zi-Long Zhang
Journal:  Int J Mol Med       Date:  2016-11-02       Impact factor: 4.101

8.  The Effects of Transdermal Estrogen Delivery on Bone Mineral Density in Postmenopausal Women: A Meta-analysis.

Authors:  Fatemeh Abdi; Hamid Mobedi; Farhad Bayat; Nariman Mosaffa; Mahrokh Dolatian; Fahimeh Ramezani Tehrani
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

9.  Identification of gene biomarkers in patients with postmenopausal osteoporosis.

Authors:  Chenggang Yang; Jing Ren; Bangling Li; Chuandi Jin; Cui Ma; Cheng Cheng; Yaolan Sun; Xiaofeng Shi
Journal:  Mol Med Rep       Date:  2018-12-12       Impact factor: 2.952

10.  Cornuside I promoted osteogenic differentiation of bone mesenchymal stem cells through PI3K/Akt signaling pathway.

Authors:  Feng Gao; Sheng-Li Xia; Xiu-Hui Wang; Xiao-Xiao Zhou; Jun Wang
Journal:  J Orthop Surg Res       Date:  2021-06-21       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.